S2MEDICAL AB SER. B chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 0.44
Dividend & YieldN/Akr (N/A)
Beta -0.27
Market capitalization 25.23M
Operating cash flow -22.71M
ESG Scores unknown

Company description

S2Medical AB (publ) develops, produces, and sells wound healing products for burns and chronic wounds. It offers Epiprotect 2117, a synthetic allograft/xenograft tissue substitutes; Epiprotect Ulcer, a wound dressing to heal acute and chronic ulcers; and washable, durable, waterproof, and self-adhesive bandages under the INSTABIND brand name, as well as NO SMELL, a perfume free odour remover. The company also distributes Silverlon dressings that deliver silver ions into the wound. In addition, it operates wound healing center under the S2Clinic name. The company was incorporated in 2013 and is headquartered in Linköping, Sweden.

Sector: Healthcare - Industry: Medical Instruments & Supplies

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities
Total Cashflows From Investing Activities -2.57M -3.15M -1.98M -3.02M
Net Borrowings -630.62k -728.22k -678.22k 9.38M
Total Cash From Financing Activities 46.27M -728.22k 24.39M 6.85M
Change To Operating Activities 2.37M 790.18k 1.01M -719.84k
Issuance Of Stock 51.06M 26.18M 26.18M
Net Income -10.73M -18.44M -15.13M -20.08M
Change In Cash 30.95M -20.98M 9.43M -15.84M
Effect Of Exchange Rate
Total Cash From Operating Activities -12.75M -17.1M -12.98M -19.67M
Depreciation 440.9k 883.33k 922.34k 919.48k
Change To Account Receivables -2.94M -213.97k 1.94M -495.09k
Other Cashflows From Financing Activities -4.16M -1.11M -1.11M -2.53M
Change To Netincome -824.51k 12.93k 31.36k 418.62k
Capital Expenditures -644.9k -644.9k -62.2k -187.53k

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development
Income Before Tax -10.73M -18.44M -15.13M -20.08M
Net Income -10.73M -18.44M -15.13M -20.08M
Selling General Administrative 14.55M 20.8M 23.06M 25.54M
Gross Profit 4.77M 3.9M 10.48M 7.42M
Ebit -10.61M -18.33M -15.06M -19.84M
Operating Income -10.61M -18.33M -15.06M -19.84M
Interest Expense -124.22k -101.29k -73.05k -243.41k
Income Tax Expense
Total Revenue 4.09M 5.6M 27.97M 10.96M
Cost Of Revenue -674.92k 1.7M 17.48M 3.54M
Total Other Income ExpenseNet -124.27k -101.25k -73k -243.41k
Net Income From Continuing Ops -10.73M -18.44M -15.13M -20.08M
Net Income Applicable To Common Shares -10.73M -18.44M -15.13M -20.08M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 5.53M 5.6M 8.49M 15M
Total Stockholder Equity 43.55M 25.11M 32.97M 14.68M
Other Current Liabilities 1.46M 1.11M 1.62M 11.64M
Total Assets 49.08M 30.71M 41.46M 29.68M
Common Stock 661.61k 661.61k 866.06k 881.68k
Other Current Assets
Retained Earnings -16.5M -34.93M -49.68M -69.75M
Treasury Stock
Cash 36.44M 15.46M 25.32M 9.48M
Total Current Liabilities 3.99M 4.77M 8.28M 15M
Other Stockholder Equity
Property, Plant, and Equipment 2.64M 2.71M 2.22M 1.74M
Total Current Assets 41.73M 21.48M 31.51M 16.26M
Net Tangible Assets 41.99M 23.87M 32.04M 12.36M
Net Receivables 2.48M 3.09M 827.65k 1.26M
Accounts Payable 780.52k 1.75M 3.61M 988.19k


Insider Transactions

Here are the insider transactions of stock shares related to S2MEDICAL AB SER. B:

Filer Name Transaction Text Ownership Date Filer Relation Shares
NO DATA

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to S2MEDICAL AB SER. B. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on S2MEDICAL AB SER. B

Here is the result of two systematic investment strategies applied to S2MEDICAL AB SER. B. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on S2MEDICAL AB SER. B

The following chart shows the equity curve of the two systematic investment strategies applied to S2MEDICAL AB SER. B:

S2MEDICAL AB SER. B automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 0% on the backtest period.

Performance at glance

Performance

0 %

Latent gain

0.0 kr

Invested capital

0.0 kr

Annualized return

0.0 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on S2MEDICAL AB SER. B

This is the result of two momentum investment strategies applied to S2MEDICAL AB SER. B. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on S2MEDICAL AB SER. B

The following chart shows all the entries opened by the momentum investment system on S2MEDICAL AB SER. B:

S2MEDICAL AB SER. B momentum entries
  • The first momentum investment strategy would give -15.83% of return on S2MEDICAL AB SER. B. That represents -39.9kr of latent gain with 252.0kr of employed capital.
  • The second momentum investment strategy would give 0% of return on S2MEDICAL AB SER. B. That represents 0.0kr of latent gain with 0.0kr of employed capital.
Performance at glance (1Q Momentum)

Performance

-15.83 %

Latent gain

-39.9 kr

Invested capital

252.0 kr

Annualized return

-0.0 %
Performance at glance (2Q Momentum)

Performance

0 %

Latent gain

0.0 kr

Invested capital

0.0 kr

Annualized return

-0.0 %

Momentum equity curve on S2MEDICAL AB SER. B

The following chart shows the equity curve of the two momentum strategies applied to S2MEDICAL AB SER. B:

S2MEDICAL AB SER. B momentum equity

Note: the dividends potentially given by S2MEDICAL AB SER. B are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on S2MEDICAL AB SER. B

The following chart shows the employed capital evolution of the two momentum strategies on S2MEDICAL AB SER. B since the beginning:

S2MEDICAL AB SER. B

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250kr, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000kr.


Buy the dip strategy result on S2MEDICAL AB SER. B

Buy the dip entry openings on S2MEDICAL AB SER. B

S2MEDICAL AB SER. B

The performance achieved by the robo-advisor on S2MEDICAL AB SER. B is 0%. That represents 0.0$ of latent gain with 0.0kr of employed capital. The following chart shows S2MEDICAL AB SER. B stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of S2MEDICAL AB SER. B, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 kr

Invested capital

0.0 kr

Annualized return

-0.0 %

Equity curve of the strategy applied to S2MEDICAL AB SER. B

The following chart shows the result of the investment strategy applied to S2MEDICAL AB SER. B:

S2MEDICAL AB SER. B

Note: the dividends potentially given by S2MEDICAL AB SER. B are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on S2MEDICAL AB SER. B

The following chart shows the employed capital evolution since the beginning of the investment strategy on S2MEDICAL AB SER. B:

S2MEDICAL AB SER. B

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on S2MEDICAL AB SER. B

In this section, I will compare the three previous investment strategies applied to S2MEDICAL AB SER. B.

Equity curve comparison on S2MEDICAL AB SER. B

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

S2MEDICAL AB SER. B investment strategy comparison

Employed capital comparison on S2MEDICAL AB SER. B

S2MEDICAL AB SER. B investment comparison

Performance comparison on S2MEDICAL AB SER. B

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 0% 0.0kr 0.0kr 0.0%
Momentum 1 quarter -15.83% -39.9kr 252.0kr -395.75%
Momentum 2 quarters 0% 0.0kr 0.0kr -0.0%
Non-directional 0% 0.0kr 0.0kr -0.0%
Annualized return comparison

Automatic investment

0.0 %

Momentum 1Q

-0.0 %

Momentum 2Q

-0.0 %

Non-directional

-0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with S2MEDICAL AB SER. B:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between S2MEDICAL AB SER. B and the other stocks. There may be false positives or some missing correlated stocks. If the price of S2MEDICAL AB SER. B does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name S2MEDICAL AB SER. B
Country Sweden
City Linköping
Address Sunnorpsgatan 5
Phone 46 87 00 00 50
Website www.s2m.se
FullTime employees 17
Industry Medical Instruments & Supplies
Sector Healthcare
Exchange XSTO
Ticker S2M.XSTO
Market www.nasdaqomxnordic.com

S2MEDICAL AB SER. B ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown